PXS-2076

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePXS-2076
Drug Alias NameTNF release inhibitor (Pharmaxis)cannabinoid CB2 agonist (Pharmaxis)PXS-2030PXS-2076PXS-2000
ClassificationSmall molecules
Mechanisms of ActionTNF release inhibitorsCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntara Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A